"Le Centre Hospitalier Intercommunal de Créteil (CHIC) assure des missions de recours et de proximité tout en proposant des prises en charge d’excellence et innovantes. L’établissement dispose du service d’urgences le plus important du 94. Il propose une prise en charge complète du couple, de la femme et de l’enfant et a également une forte activité en cancérologie. Il dispose d’un service universitaire d’ophtalmologie de pointe. Le CHIC est un hôpital universitaire et un centre de recherche conventionné par la faculté de médecine Paris Est Créteil 94 pour 9 disciplines hospitalo-universitaires. Avec le CHI de Villeneuve St Georges, il appartient au groupement hospitalier de territoire Hôpitaux Confluence Val -de-Marne Essonne."

During the past decade, Centre Hospitalier Intercommunal; Service de Pneumologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Intercommunal; Service de Pneumologie" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Groupe Français de Pneumologie Cancérologie (GFPC)" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Intercommunal; Service de Pneumologie" are "Non-Squamous Non-Small Cell Lung Cancer" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Lung Neoplasms" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centre Hospitalier Intercommunal; Service de Pneumologie" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Intercommunal; Service de Pneumologie" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (4 trials), "Atezolizumab" (3 trials), "Pemetrexed" (2 trials), "Alectinib" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Intercommunal; Service de Pneumologie" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier Intercommunal; Service de Pneumologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centre Hospitalier Intercommunal; Service de Pneumologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Intercommunal; Service de Pneumologie, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".